QRG Capital Management’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-4,992
Closed -$260K 1065
2025
Q2
$260K Sell
4,992
-334
-6% -$18.3K ﹤0.01% 1005
2025
Q1
$322K Buy
5,326
+350
+7% +$22.6K ﹤0.01% 896
2024
Q4
$341K Sell
4,976
-851
-15% -$59.3K ﹤0.01% 873
2024
Q3
$419K Buy
5,827
+280
+5% +$19.8K ﹤0.01% 823
2024
Q2
$384K Buy
5,547
+442
+9% +$32.2K ﹤0.01% 811
2024
Q1
$409K Sell
5,105
-795
-13% -$70.9K 0.01% 808
2023
Q4
$646K Buy
5,900
+154
+3% +$15.9K 0.01% 641
2023
Q3
$580K Buy
+5,746
New +$660K 0.01% 615

Other funds holding CNMD

QRG Capital Management's CNMD Position: Q3 2025 in Review

QRG Capital Management sold out of CONMED (CNMD) in Q3 2025, closing a stake of 4,992 shares — an estimated $260K sold.

QRG Capital Management first reported a position in CNMD in Q3 2023 and held it in 8 quarters. The position peaked at $646K in Q4 2023. 273 funds tracked by Wall St. Rank hold CNMD as of Q3 2025.

  • QRG Capital Management reported no remaining CONMED position as of Q3 2025 after selling out during the quarter.
  • QRG Capital Management sold 4,992 CONMED shares in Q3 2025, an estimated $260K.
  • QRG Capital Management first reported a position in CONMED in Q3 2023 and held it in 8 quarters.
  • QRG Capital Management's CONMED position peaked at $646K in Q4 2023.
  • 273 funds tracked by Wall St. Rank held CONMED as of Q3 2025.

Based on QRG Capital Management's 13F filing for Q3 2025, filed 28 Oct 2025.